620
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of factors associated with survival in allogeneic stem cell-transplanted patients admitted to the intensive care unit (ICU)

, , , , &
Article: 2256198 | Received 02 May 2023, Accepted 29 Aug 2023, Published online: 22 Sep 2023

References

  • Gratwohl A, Pasquini MC, Aljurf M, et al. Worldwide network for blood and marrow transplantation (WBMT). One million haemopoietic stem-cell transplants: a retrospective observational study. Lancet Haematol. 2015 Mar;2(3):e91–100. doi:10.1016/S2352-3026(15)00028-9. Epub 2015 Feb 27. Erratum in: Lancet Haematol. 2015 May;2(5):e184.
  • Kew AK, Couban S, Patrick W, et al. Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit. Biol Blood Marrow Transp. 2006 Mar;12(3):301–305. doi:10.1016/j.bbmt.2005.10.020.
  • Pène F, Aubron C, Azoulay E, et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol. 2006 Feb 1;24(4):643–649. doi:10.1200/JCO.2005.03.9073. Epub 2005 Dec 27.
  • Afessa B, Tefferi A, Hoagland HC, et al. Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc. 1992 Feb;67(2):117–122. doi:10.1016/s0025-6196(12)61310-x.
  • Faber-Langendoen K, Caplan AL, McGlave PB. Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use. Bone Marrow Transp. 1993 Nov;12(5):501–507.
  • Torrecilla C, Cortés JL, Chamorro C, et al. Prognostic assessment of the acute complications of bone marrow transplantation requiring intensive therapy. Intens Care Med. 1988;14(4):393–398. doi:10.1007/BF00262895.
  • Bayraktar UD, Nates JL. Intensive care outcomes in adult hematopoietic stem cell transplantation patients. World J Clin Oncol. 2016 Feb;7(1):98–105. doi:10.5306/wjco.v7.i1.98.
  • Mayer S, Pastores SM, Riedel E, et al. Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peritransplant period. Leuk Lymphoma. 2017 Feb;58(2):382–390. doi:10.1080/10428194.2016.1195499. Epub 2016 Jun 27.
  • Azoulay E, Lemiale V, Mokart D, et al. Acute respiratory distress syndrome in patients with malignancies. Intens Care Med. 2014 Aug;40(8):1106–1114. doi:10.1007/s00134-014-3354-0. Epub 2014 Jun 5.
  • Pène F, Percheron S, Lemiale V, et al. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med. 2008 Mar;36(3):690–696. doi:10.1097/CCM.0B013E318165314B.
  • Benz R, Schanz U, Maggiorini M, et al. Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT. Bone Marrow Transp. 2014 Jan;49(1):62–65. doi:10.1038/bmt.2013.141. Epub 2013 Sep 23.
  • Lueck C, Stadler M, Koenecke C, et al. Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients. Intens Care Med. 2018 Sep;44(9):1483–1492. doi:10.1007/s00134-018-5347-x. Epub 2018 Aug 23.
  • Borrega JG, Heger JM, Koehler P, et al. Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes-results of a retrospective analysis from a German university hospital. Ann Hematol. 2022 Feb;101(2):389–395. doi:10.1007/s00277-021-04698-3 Epub 2021 Oct 20.
  • Platon L, Amigues L, Ceballos P, et al. A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009-2013). Bone Marrow Transp. 2016 Feb;51(2):256–261. doi:10.1038/bmt.2015.269. Epub 2015 Nov 16.
  • Mayer S, Pastores SM, Riedel E, et al. Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peritransplant period. Leuk Lymphoma. 2017 Feb;58(2):382–390. doi:10.1080/10428194.2016.1195499. Epub 2016 Jun 27.
  • Mayer S. Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien: abstracts. Oncol Res Treat. 2022;45(suppl 2):152. doi:10.1159/000526456
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016 Feb;315(8):801–810. doi:10.1001/jama.2016.0287.
  • Gratwohl A. The EBMT risk score. Bone Marrow Transp. 2012 Jun;47(6):749–756. doi:10.1038/bmt.2011.110 Epub 2011 Jun 6.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8.
  • Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005 Oct 15;106(8):2912–2919. doi:10.1182/blood-2005-05-2004 Epub 2005 Jun 30.
  • Lambden S, Laterre PF, Levy MM, et al. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019 Nov 27;23(1):374, doi:10.1186/s13054-019-2663-7.
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016 Feb 23;315(8):801–810. doi:10.1001/jama.2016.0287.
  • Bayraktar UD, Milton DR, Shpall EJ, et al. Prognostic index for critically Ill allogeneic transplantation patients. Biol Blood Marrow Transp. 2017 Jun;23(6):991–996. doi:10.1016/j.bbmt.2017.03.003. Epub 2017 Mar 3.
  • Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/north American multicenter study. JAMA. 1993 Dec 22-29;270(24):2957–2963. doi:10.1001/jama.270.24.2957. Erratum in: JAMA 1994 May 4;271(17):1321.
  • Knaus WA, Zimmerman JE, Wagner DP, et al. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med. 1981 Aug;9(8):591–597. doi:10.1097/00003246-198108000-00008.
  • Lengliné E, Chevret S, Moreau AS, et al. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transp. 2015 Jun;50(6):840–845. doi:10.1038/bmt.2015.55 Epub 2015 Mar 23.
  • Lindgaard SC, Nielsen J, Lindmark A, et al. Prognosis of allogeneic haematopoietic stem cell recipients admitted to the intensive care unit: a retrospective, single-centre study. Acta Haematol. 2016;135(2):72–78. doi:10.1159/000440937 Epub 2015 Oct 20.
  • Tanaka A, Uchiyama A, Kitamura T, et al. Association between tracheostomy and survival in patients with coronavirus disease 2019 who require prolonged mechanical ventilation for more than 14 days: a multicenter cohort study. Auris Nasus Larynx. 2022 Jun. S0385-8146(22)00164-X. doi: 10.1016/j.anl.2022.06.002. Epub ahead of print.
  • Neumann F, Lobitz O, Fenk R, et al. The sepsis-related organ failure assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantation. Ann Hematol. 2008 Apr;87(4):299–304. doi:10.1007/s00277-008-0440-9 Epub 2008 Jan 25.
  • Bauer M, Groesdonk HV, Preissing F, et al. Sterblichkeit bei Sepsis und septischem Schock in Deutschland. Ergebnisse eines systematischen reviews mit Metaanalyse [Mortality in sepsis and septic shock in Germany. Results of a systematic review and meta-analysis]. Anaesthesist. 2021 Aug;70(8):673–680. doi:10.1007/s00101-021-00917-8. German Epub 2021 Feb 9. Erratum in: Anaesthesist. 2021 Jun 21.
  • Bayraktar UD, Milton DR, Shpall EJ, et al. Prognostic index for critically ill allogeneic transplantation patients. Biol Blood Marrow Transp. 2017 Jun;23(6):991–996. doi:10.1016/j.bbmt.2017.03.003. Epub 2017 Mar 3.
  • Michel CS, Teschner D, Schmidtmann I, et al. Prognostic factors and outcome of adult allogeneic hematopoietic stem cell transplantation patients admitted to intensive care unit during transplant hospitalization. Sci Rep. 2019 Dec;9(1):19911, doi:10.1038/s41598-019-56322-0.
  • Bayraktar UD, Shpall EJ, Liu P, et al. Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit. J Clin Oncol. 2013 Nov 20;31(33):4207–4214. doi:10.1200/JCO.2013.50.5867 Epub 2013 Oct 14.
  • Turki AT, Lamm W, Schmitt C, et al. Platelet number and graft function predict intensive care survival in allogeneic stem cell transplantation patients. Ann Hematol. 2019;98:491–500. doi:10.1007/s00277-018-3538-8